Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Aciclovir 3%{relative}
GlaxoSmithKline NZ Limited
Aciclovir 3% w/w
3% w/w
Eye ointment
Active: Aciclovir 3%{relative} Excipient: White soft paraffin
Tube, 4.5 g
Prescription
Prescription
Mylan Laboratories Limited
Treatment of Herpes simplex keratitis.
Package - Contents - Shelf Life: Tube, - 4.5 g - 60 months from date of manufacture stored at or below 25°C
1982-11-18
1 ZOVIRAX ® _(ZO-VI-RAX)_ OPHTHALMIC (EYE) OINTMENT ACICLOVIR 3%W/W WHAT IS IN THIS LEAFLET This leaflet answers some common questions about ZOVIRAX eye ointment. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. Please read this leaflet before you start using ZOVIRAX eye ointment. If you are helping someone else use ZOVIRAX eye ointment, please read this leaflet before you use it the first time. All medicines have risks and benefits. Your doctor has weighed the expected benefits against possible risks of you using ZOVIRAX eye ointment. If you have any concerns about using this medicine, ask your doctor or pharmacist. Keep this leaflet with the medicine. You may need to read it again. WHAT ZOVIRAX EYE OINTMENT IS USED FOR ZOVIRAX eye ointment is an antiviral used to treat an eye infection called Herpes simplex keratitis. This is a viral infection in the eye. It is NOT used in other infections in the eye such as conjunctivitis. This medicine is available only with a doctor’s prescription. BEFORE YOU USE ZOVIRAX EYE OINTMENT _DO NOT USE ZOVIRAX EYE OINTMENT IF: _ you have an allergy to ZOVIRAX eye ointment, acyclovir, valaciclovir or any of the ingredients listed at the end of this leaflet. the packaging is torn or shows signs of tampering, or the ointment has changed colour. the expiry date (EXP) printed on the pack has passed. If you use this medicine after the expiry date has passed, it may not work. it is more than a month after you first opened the tube of ointment. If you are not sure whether you should start using ZOVIRAX eye ointment, contact your doctor. Do not give this medicine to anyone else. Your doctor has Read the complete document
1 DATA SHEET ZOVIRAX OPHTHALMIC OINTMENT. _ACICLOVIR 3% W/W OPHTHALMIC OINTMENT_ PRESENTATION A near-white translucent eye ointment containing 3%w/w aciclovir in a sterile, anhydrous, soft paraffin base. _NATURE AND CONTENTS OF CONTAINER:_ Tube with nozzle and screw cap: 4.5g. USES _ACTIONS:_ Aciclovir is an antiviral agent which is highly active _in vitro _against Herpes simplex (HSV) types I and II and Varicella zoster viruses, but its toxicity to mammalian cells is low. Aciclovir is phosphorylated to the active compound aciclovir triphosphate after entry into a herpes infected cell. The first step in this process requires the presence of the viral-coded thymidine kinase. Aciclovir triphosphate acts as an inhibitor of and substrate for the herpes specified DNA polymerase preventing further viral DNA synthesis without affecting normal cellular processes. _PHARMACOKINETICS:_ Aciclovir is rapidly absorbed from the ophthalmic ointment through the corneal epithelium and superficial ocular tissues with the result that viral toxic concentrations are achieved in the aqueous humor. It has not been possible to detect aciclovir in the blood by existing methods after topical application of ZOVIRAX Ophthalmic Ointment, but trace quantities are detectable in the urine. These levels, however, are not therapeutically significant. _INDICATIONS:_ ZOVIRAX Ophthalmic Ointment is indicated for the treatment of Herpes simplex keratitis. DOSAGE AND ADMINISTRATION 2 The dosage for all age groups is the same. A 10mm ribbon of the ointment should be placed inside the lower conjunctival sac five times a day at approximately four hourly intervals. Treatment should continue for at least 3 days after healing. CONTRAINDICATIONS ZOVIRAX Ophthalmic Ointment is contraindicated in patients known to be hypersensitive to aciclovir or valaciclovir. WARNINGS AND PRECAUTIONS Patients should be informed that transient mild stinging immediately following application may occur. Pati Read the complete document